Canada markets closed

CRISPR Therapeutics AG (1CG.SG)

Stuttgart - Stuttgart Delayed Price. Currency in EUR
Add to watchlist
40.800.00 (0.00%)
At close: 08:10AM CEST
Show:
Income Statement
Balance Sheet
Annual

Cash Flow

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Cash flows from operating activities
Net Income
-153,610
-153,610
-650,175
377,661
-348,865
Depreciation & amortization
19,837
19,837
24,172
17,953
9,184
Stock based compensation
81,028
81,028
97,947
102,390
66,018
Change in working capital
-193,585
-193,585
19,845
26,859
33,440
Accounts receivable
-200,000
-200,000
305
-161
-45
Other working capital
-272,345
-272,345
-532,929
457,267
-256,724
Other non-cash items
-14,045
-14,045
12,470
14,109
1,857
Net cash provided by operating activites
-260,375
-260,375
-495,741
538,972
-238,366
Cash flows from investing activities
Investments in property, plant and equipment
-11,970
-11,970
-37,188
-81,705
-18,358
Purchases of investments
-1,065,911
-1,065,911
-1,417,800
-1,509,327
-593,998
Sales/Maturities of investments
1,452,528
1,452,528
1,196,333
555,602
71,186
Net cash used for investing activites
374,647
374,647
-258,655
-1,035,430
-541,170
Cash flows from financing activities
Common stock issued
32,721
32,721
970
213,267
982,289
Common stock repurchased
-
-
-
-
0
Net cash used privided by (used for) financing activities
62,664
62,664
38,592
250,945
1,016,152
Net change in cash
177,009
177,009
-715,884
-245,524
236,656
Cash at beginning of period
224,060
224,060
939,944
1,185,468
948,812
Cash at end of period
401,068
401,068
224,060
939,944
1,185,468
Free Cash Flow
Operating Cash Flow
-260,375
-260,375
-495,741
538,972
-238,366
Capital Expenditure
-11,970
-11,970
-37,188
-81,705
-18,358
Free Cash Flow
-272,345
-272,345
-532,929
457,267
-256,724